Alternative triggering molecules and single chain bispecific antibodies
- PMID: 8581372
- DOI: 10.1089/scd.1.1995.4.377
Alternative triggering molecules and single chain bispecific antibodies
Abstract
Although T cell receptors and Fc receptors are the best known cytotoxic triggering molecules, a number of adhesion molecules recently have been identified as alternative triggering molecules. We discuss how CD44, an adhesion molecule found on all leukocytes and many other cell types, becomes a triggering molecule on NK cells following stimulation with IL-2. We also describe a genetically engineered single chain bispecific antibody, produced in mammalian cells and in bacteria, that is capable of redirecting lysis in the nanogram per milliliter range.
Similar articles
-
CD44 is a cytotoxic triggering molecule in human peripheral blood NK cells.J Immunol. 1994 Dec 15;153(12):5473-81. J Immunol. 1994. PMID: 7527443
-
Redirection of cellular cytotoxicity. A two-step approach using recombinant single-chain Fv molecules.Cell Biophys. 1995 Jun;26(3):153-65. doi: 10.1007/BF02791577. Cell Biophys. 1995. PMID: 8521448 Review.
-
Properties of bispecific single chain antibodies expressed in Escherichia coli.J Hematother. 1995 Oct;4(5):403-8. doi: 10.1089/scd.1.1995.4.403. J Hematother. 1995. PMID: 8581376
-
Redirection of T cell-mediated cytotoxicity by a recombinant single-chain Fv molecule.J Immunol. 1994 Feb 15;152(4):1802-11. J Immunol. 1994. PMID: 8120389
-
RECRUIT-TandAbs: harnessing the immune system to kill cancer cells.Future Oncol. 2012 Jun;8(6):687-95. doi: 10.2217/fon.12.54. Future Oncol. 2012. PMID: 22764766 Review.
Cited by
-
Antibody-directed effector cell therapy of tumors: analysis and optimization using a physiologically based pharmacokinetic model.Neoplasia. 2002 Sep-Oct;4(5):449-63. doi: 10.1038/sj.neo.7900260. Neoplasia. 2002. PMID: 12192604 Free PMC article.
-
The making of bispecific antibodies.MAbs. 2017 Feb/Mar;9(2):182-212. doi: 10.1080/19420862.2016.1268307. MAbs. 2017. PMID: 28071970 Free PMC article. Review.
-
Immunotherapy as a Turning Point in the Treatment of Acute Myeloid Leukemia.Cancers (Basel). 2021 Dec 13;13(24):6246. doi: 10.3390/cancers13246246. Cancers (Basel). 2021. PMID: 34944865 Free PMC article. Review.
-
Symmetry breaking: bispecific antibodies, the beginnings, and 50 years on.Cancer Immun. 2012;12:12. Epub 2012 May 1. Cancer Immun. 2012. PMID: 22896757 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous